Christopher Rowland

Senators say they are disturbed by walkway deaths and understaffing at costly assisted-living facilities, a pattern revealed by a recent Post investigation.

The Senate Special Committee on Aging is demanding answers from the industry after The Washington Post detailed nearly 100 preventable walkaway deaths across the country.

His story shows how a few bad life turns can send Americans — even vulnerable elderly people with dementia — into the streets.

Since 2018, more than 2,000 people have wandered away from assisted-living and memory-care facilities, according to The Post’s investigation. Nearly 100 have died.

Reporters who investigated deadly walkaways at assisted-living facilities answered questions from readers Tuesday.

Patients are confronted with denials by both private insurance companies and the Social Security Administration as they fight for disability benefits for the debilitating symptoms of long covid. Many are forced to retain lawyers and may end up in federal court.

Companies face a big test in 2022 as they tweak vaccines, dosages and boosters to meet the threat of coronavirus mutations.

A 10-year legal saga over inflated Medicare billings at a Florida-based nursing home chain is likely to end with only a small payment for U.S. taxpayers.

As the threat of the delta variant grows, nursing home chains also are beginning to adopt vaccine mandates, including the largest nonprofit and for-profit chains.

Emergent BioSolutions says the FDA allowed it to restart production after a lengthy suspension, an interim step toward winning full manufacturing authorization of Johnson & Johnson coronavirus vaccine.

Senior administration officials have stressed the importance of redundancy in vaccine supply to prepare for the possible need to administer booster shots against mutated variants, as well as the potential of shots for children under 16 early next year.

Lower-than-anticipated allocations have spawned widespread confusion and concern in states, which are beginning to grasp the level of vaccine scarcity they will confront in the early going of the massive vaccination campaign.

The White House directed the distribution of 23 million ineffective and potentially dangerous hydroxychloroquine tablets to coronavirus patients in hard-hit areas around the country, setting aside the mandatory safety controls put in place by the Food and Drug Administration.

The commercial success of remdesivir, despite its narrow benefit for hospitalized coronavirus patients, highlights the lack of potent tools for doctors six months into the pandemic.

Nine chief executives issued an extraordinary joint statement Tuesday seeking to bolster faith in coronavirus vaccine.

Elizabeth Warren, others seek details of Warp Speed co-chief ... - The Washington Post

The company, which produces vaccines through genetic engineering, is conducting a Phase 1 safety trial in Australia of an experimental vaccine.

In its race to control covid-19, the federal government is spending billions in agreements with pharmaceutical companies to subsidize development of medicines. But it is employing a looser standard of federal contracting that avoids some rules that protect taxpayer investments, said Knowledge Ecolog…

The emotional and financial costs are high in a long-term care system that is full of holes

Rates of death in the groups treated with the drugs were worse than for those who received no treatment, and rates of patients on ventilators were similar, the study found.